Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021

The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily based on age; by 7th March 2021 approximately 93% of the English population aged 70+ years had received at least 1 dose of either the Pfizer BioNTech or AstraZeneca vaccines. Using a nucleoprotein assay that detec...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitaker, Heather J, Elgohari, Suzanne, Rowe, Cathy, Otter, Ashley David, Brooks, Tim, Linley, Ezra, Hayden, Iain, Ribeiro, Sonia, Hewson, Jacqueline, Lakhani, Anissa, Clarke, Eleanor, Tsang, Camille, Campbell, Colin NJ, Ramsay, Mary, Brown, Kevin, Amirthalingam, Gayatri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of The British Infection Association. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110696/
https://www.ncbi.nlm.nih.gov/pubmed/33989631
http://dx.doi.org/10.1016/j.jinf.2021.04.037
_version_ 1783690342892044288
author Whitaker, Heather J
Elgohari, Suzanne
Rowe, Cathy
Otter, Ashley David
Brooks, Tim
Linley, Ezra
Hayden, Iain
Ribeiro, Sonia
Hewson, Jacqueline
Lakhani, Anissa
Clarke, Eleanor
Tsang, Camille
Campbell, Colin NJ
Ramsay, Mary
Brown, Kevin
Amirthalingam, Gayatri
author_facet Whitaker, Heather J
Elgohari, Suzanne
Rowe, Cathy
Otter, Ashley David
Brooks, Tim
Linley, Ezra
Hayden, Iain
Ribeiro, Sonia
Hewson, Jacqueline
Lakhani, Anissa
Clarke, Eleanor
Tsang, Camille
Campbell, Colin NJ
Ramsay, Mary
Brown, Kevin
Amirthalingam, Gayatri
author_sort Whitaker, Heather J
collection PubMed
description The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily based on age; by 7th March 2021 approximately 93% of the English population aged 70+ years had received at least 1 dose of either the Pfizer BioNTech or AstraZeneca vaccines. Using a nucleoprotein assay that detects antibodies following natural infection only and a spike assay that detects infection and vaccine-induced responses, we aim to describe the impact of vaccination on SARS-CoV-2 antibody prevalence in English blood donors.
format Online
Article
Text
id pubmed-8110696
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd on behalf of The British Infection Association.
record_format MEDLINE/PubMed
spelling pubmed-81106962021-05-11 Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021 Whitaker, Heather J Elgohari, Suzanne Rowe, Cathy Otter, Ashley David Brooks, Tim Linley, Ezra Hayden, Iain Ribeiro, Sonia Hewson, Jacqueline Lakhani, Anissa Clarke, Eleanor Tsang, Camille Campbell, Colin NJ Ramsay, Mary Brown, Kevin Amirthalingam, Gayatri J Infect Letter to the Editor The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily based on age; by 7th March 2021 approximately 93% of the English population aged 70+ years had received at least 1 dose of either the Pfizer BioNTech or AstraZeneca vaccines. Using a nucleoprotein assay that detects antibodies following natural infection only and a spike assay that detects infection and vaccine-induced responses, we aim to describe the impact of vaccination on SARS-CoV-2 antibody prevalence in English blood donors. Published by Elsevier Ltd on behalf of The British Infection Association. 2021-08 2021-05-11 /pmc/articles/PMC8110696/ /pubmed/33989631 http://dx.doi.org/10.1016/j.jinf.2021.04.037 Text en Crown Copyright © 2021 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Whitaker, Heather J
Elgohari, Suzanne
Rowe, Cathy
Otter, Ashley David
Brooks, Tim
Linley, Ezra
Hayden, Iain
Ribeiro, Sonia
Hewson, Jacqueline
Lakhani, Anissa
Clarke, Eleanor
Tsang, Camille
Campbell, Colin NJ
Ramsay, Mary
Brown, Kevin
Amirthalingam, Gayatri
Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
title Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
title_full Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
title_fullStr Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
title_full_unstemmed Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
title_short Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
title_sort impact of covid-19 vaccination program on seroprevalence in blood donors in england, 2021
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110696/
https://www.ncbi.nlm.nih.gov/pubmed/33989631
http://dx.doi.org/10.1016/j.jinf.2021.04.037
work_keys_str_mv AT whitakerheatherj impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT elgoharisuzanne impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT rowecathy impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT otterashleydavid impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT brookstim impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT linleyezra impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT haydeniain impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT ribeirosonia impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT hewsonjacqueline impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT lakhanianissa impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT clarkeeleanor impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT tsangcamille impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT campbellcolinnj impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT ramsaymary impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT brownkevin impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021
AT amirthalingamgayatri impactofcovid19vaccinationprogramonseroprevalenceinblooddonorsinengland2021

Ejemplares similares